|
|
|
Insider
Information: |
Pelossof Avi |
Relationship: |
GlobalPres, Infectious... |
City: |
Medford |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
377,558 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$171,789 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
377,558 |
|
|
Total
Value |
$171,789 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Chembio Diagnostics Inc |
CEMI |
VP Sales, Marketing & BD |
2007-01-19 |
377,558 |
|
0 |
Premium* |
|
Alere Inc |
ALR |
GlobalPres, Infectious... |
2017-10-03 |
0 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
20 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ALR |
Alere Inc |
GlobalPres, Infectious Disease |
|
2017-10-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(26,005) |
0 |
0 |
- |
|
ALR |
Alere Inc |
GlobalPres, Infectious Disease |
|
2017-08-31 |
4 |
D |
$49.46 |
$121,869 |
D/D |
(2,464) |
26,005 |
0 |
- |
|
ALR |
Alere Inc |
GlobalPres, Infectious Disease |
|
2017-08-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,667 |
28,469 |
0 |
- |
|
ALR |
Alere Inc |
GlobalPres, Infectious Disease |
|
2017-02-16 |
4 |
D |
$40.40 |
$148,066 |
D/D |
(3,665) |
21,802 |
0 |
- |
|
ALR |
Alere Inc |
GlobalPres, Infectious Disease |
|
2017-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,736 |
24,543 |
0 |
- |
|
ALR |
Alere Inc |
GlobalPres, Infectious Disease |
|
2016-12-30 |
4 |
OE |
$38.70 |
$1,548,000 |
D/D |
40,000 |
25,994 |
0 |
- |
|
ALR |
Alere Inc |
GlobalPres, Infectious Disease |
|
2016-12-30 |
4 |
D |
$38.96 |
$1,551,131 |
D/D |
(39,793) |
15,731 |
0 |
- |
|
ALR |
Alere Inc |
GlobalPres, Infectious Disease |
|
2016-09-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,667 |
15,524 |
0 |
- |
|
ALR |
Alere Inc |
GlobalPres, Infectious Disease |
|
2015-08-31 |
4 |
D |
$51.97 |
$128,054 |
D/D |
(2,464) |
8,857 |
0 |
- |
|
ALR |
Alere Inc |
GlobalPres, Infectious Disease |
|
2015-08-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,666 |
11,321 |
0 |
- |
|
ALR |
Alere Inc |
Pres., Infectious DiseaseOffic |
|
2013-03-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,655 |
|
- |
|
CEMI |
Chembio Diagnostics Inc |
VP Sales, Marketing & BD |
|
2007-01-19 |
4 |
OE |
$0.62 |
$31,000 |
D/D |
50,000 |
377,558 |
0 |
- |
|
CEMI |
Chembio Diagnostics Inc |
VP Sales, Marketing & BD |
|
2006-12-27 |
4 |
OE |
$0.60 |
$60,000 |
D/D |
100,000 |
327,558 |
0 |
- |
|
CEMI |
Chembio Diagnostics Inc |
VP Sales, Marketing & B.D. |
|
2006-11-15 |
4 |
A |
$0.00 |
$0 |
D/D |
290 |
227,558 |
0 |
- |
|
CEMI |
Chembio Diagnostics Inc |
Vice President |
|
2006-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
403 |
227,268 |
|
- |
|
CEMI |
Chembio Diagnostics Inc |
Vice President |
|
2006-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
106 |
226,865 |
|
- |
|
CEMI |
Chembio Diagnostics Inc |
Vice President |
|
2005-11-15 |
4 |
A |
$0.60 |
$242 |
D/D |
403 |
226,759 |
|
- |
|
CEMI |
Chembio Diagnostics Inc |
Vice President |
|
2005-05-14 |
4 |
A |
$0.60 |
$239 |
D/D |
399 |
226,356 |
|
- |
|
CEMI |
Chembio Diagnostics Inc |
Vice President |
|
2004-11-15 |
4 |
A |
$0.60 |
$242 |
D/D |
403 |
225,957 |
|
- |
|
CEMI |
Chembio Diagnostics Inc |
Vice PresidentOfficer |
|
2004-05-05 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
225,554 |
|
- |
|
20 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|